|
INTI Inhibitor Therapeutics Inc 1042418 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-613,933.00 |
| Balance Sheet |
|
Current Assets
|
$586,806.00 |
|
Assets
|
$637,190.00 |
|
Current Liabilities
|
$174,894.00 |
|
Liabilities
|
$3,196,460.00 |
|
Equity
|
$-2,559,270.00 |
|
Shares Out
|
173791968.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,859,735.00 |
| Market Analysis |
Market Cap
|
$15,641,277.12 |
|
Price
|
$0.09 |
|
PB
|
0.93 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:50 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INTI documents filed with the SEC.
INTI Filings
Clear
